Ritonavir and Topical Ocular Corticosteroid Induced Cushing’s Syndrome in an Adolescent With HIV-1 Infection

    loading  Checking for direct PDF access through Ovid

Abstract

Cushing’s syndrome after topical ocular corticosteroid use is extremely rare. We describe a case of symptomatic Cushing’s syndrome in an adolescent male with sight-threatening vernal keratoconjunctivitis on antiretroviral therapy for HIV-1 infection that included ritonavir, a potent cytochrome p450 CYP3A4 inhibitor. CYP3A4 inhibition reduces the metabolism of exogenous corticosteroids leading to suppression of endogenous steroid production and Cushing’s syndrome.

Related Topics

    loading  Loading Related Articles